Source: Annual Congress 2010 - Nutrition and cancer



Rating:

Share or cite this content

Citations should be made in the following way:
M. Christofidou-Solomidou (Philadelphia, United States of America). Chemoprevention and treatment of thoracic malignancies through nutritional agents: an update on pre-clinical studies. Annual Congress 2010 - Nutrition and cancer

Member's Comments

No comment yet.

Related content which might interest you: TKIs: a new class of drugs in the management of lung cancer Source: Annual Congress 2011 - Recent therapeutic advances with tyrosine-kinase inhibitors in nonsmall-cell lung cancer Year: 2011 Rationale and targets of immunotherapy in thoracic malignancies Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies? Year: 2016 Drug development: news from “hot” early stage clinical trials: personalised immunotherapy for lung cancer Source: International Congress 2017 – Scientific year in review Year: 2017 Novel aspects in lung cancer pathology: how does it help for selecting chemotherapy? Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010 Treatment of thoracic malignancies with photodynamic therapy Source: Annual Congress 2010 - New advances in the use of lasers for treatment Year: 2010 Thoracic malignancies and nutrition: epidemiological clues for a link? Source: Annual Congress 2010 - Nutrition and cancer Year: 2010 Commentary: The ERS/ESTS clinical guidelines for evaluating fitness for radical treatment for lung cancer Source: Breathe 2008; 6: 141-145 Year: 2009 Immunotherapy: a new standard of care in thoracic malignancies? Source: Eur Respir J, 51 (2) 1702072; 10.1183/13993003.02072-2017 Year: 2018 Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer? Source: Eur Respir J 2003; 22: 535-541 Year: 2003 Other malignancies: prevention and treatment Source: School Course 2012 - Lung Transplantation Year: 2012 Lung disease induced by newer therapies for lung cancer: an update Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006 Current data on predictive markers for anti-angiogenic therapy in thoracic tumours Source: Eur Respir J 2010; 36: 915-924 Year: 2010 Cardiovascular effects of innovative therapies in lung cancer Source: Eur Respir Monogr 2020; 88: 154-166 Year: 2020 Approaches to radiological staging of mesothelioma relating to modern treatment modalities Source: Virtual Congress 2021 – Thoracic oncology Year: 2021 Perioperative systemic therapy in resectable lung cancer: from standard operating procedures to immuno-oncology and back Source: Virtual Congress 2020 – Thoracic oncology Year: 2020